Lipella Pharmaceuticals Faces Delisting Concerns
Ticker: LIPO · Form: 8-K · Filed: May 16, 2025 · CIK: 1347242
| Field | Detail |
|---|---|
| Company | Lipella Pharmaceuticals Inc. (LIPO) |
| Form Type | 8-K |
| Filed Date | May 16, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
Lipella Pharmaceuticals might get delisted, stock could be in trouble.
AI Summary
Lipella Pharmaceuticals Inc. filed an 8-K on May 16, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company's principal executive office is located at 7800 Susquehanna St., Suite 505, Pittsburgh, PA 15208.
Why It Matters
This filing indicates potential issues with Lipella Pharmaceuticals' continued listing on an exchange, which could significantly impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's trading status and market value.
Key Players & Entities
- Lipella Pharmaceuticals Inc. (company) — Registrant
- May 16, 2025 (date) — Date of Report
- May 12, 2025 (date) — Earliest Event Reported
- 7800 Susquehanna St., Suite 505, Pittsburgh, PA 15208 (address) — Registrant's principal executive office
- (412) 894-1853 (phone_number) — Registrant's telephone number
FAQ
What specific listing rule or standard has Lipella Pharmaceuticals failed to satisfy?
The filing does not specify the exact listing rule or standard that Lipella Pharmaceuticals has failed to satisfy, only that a notice has been issued.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated May 12, 2025.
What is the principal executive office address for Lipella Pharmaceuticals Inc.?
The principal executive office is located at 7800 Susquehanna St., Suite 505, Pittsburgh, PA 15208.
What is the telephone number for Lipella Pharmaceuticals Inc.?
The telephone number is (412) 894-1853.
What is the filing date of this 8-K report?
The filing date of this 8-K report is May 16, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 16, 2025 regarding LIPELLA PHARMACEUTICALS INC. (LIPO).